Ekbom’s syndrome in a bipolar disorder patient: a case report
DOI:
https://doi.org/10.25118/2763-9037.2021.v11.213Keywords:
delusional parasitosis, bipolar disorders, lurasidoneAbstract
Introduction: Ekbom syndrome is a rare condition in which the patient believes that his or her body is infested by worms or other parasites.This condition is associated to mental ilness in 81% of cases. There is not a final statement about the best psychofarmacological treatment of this condition. Objective: The present study presents a case report on which an elderly woman with bipolar disorder has shown Ekbom syndrome. Method: This study lists a case report of a 69 yerar-old woman with bipolar disorder. This patient had presented the belief that worms were walking under her skin during the past few months. She had a previous diagnosis of bipolar disorder. Depressive symptoms were intense. The patient was followed up in an outpatient psychiatric service for 120 days. Lurasidone was introduced and some drugs were discontinued. Result: One month after starting treatment with lurasidone, there was a significant improvement of delusional beliefs of Ekbom syndrome. Such improvement was associated with the improvement of the bipolar depressive condition in this case. Conclusion: Ekbom syndrome is a rare kind of delusion. Its etiology is not fully understood. We presented a case of an elderly woman with previous diagnosis of bipolar disorder with Ekbom syndrome. To our knowledge, there are no other case reports informing the use of lurasidone in bipolar depression associated with Ekbom syndrome.
Downloads
Metrics
References
Garcia-Mingo A, Dawood N, Watson J, Chiodini PL. Samples From Cases of Delusional Parasitosis as Seen in the UK Parasitology Reference Laboratory (2014-2015). Open Forum Infect Dis. 2019;6(10):ofz440. https://doi.org/10.1093/ofid/ofz440 - PMid:31660383 - PMCid:PMC6810309
Vijay A, Becker JE, Ross JS. Patterns and predictors of off-label prescription of psychiatric drugs. PLoS One. 2018;13(7):e0198363. https://doi.org/10.1371/journal.pone.0198363 PMid:30024873 - PMCid:PMC6053129
Meltzer HY, Cucchiaro J, Silva R, Ogasa M, Phillips D, Xu J, et al. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. Am J Psychiatry. 2011;168(9):957-67. https://doi.org/10.1176/appi.ajp.2011.10060907 - PMid:21676992
Loebel A, Cucchiaro J, Silva R, Kroger H, Hsu J, Sarma K, et al. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2014;171(2):160-8. - https://doi.org/10.1176/appi.ajp.2013.13070984
https://doi.org/10.1176/appi.ajp.2013.13070985
Pikalov A, Tsai J, Mao Y, Silva R, Cucchiaro J, Loebel A. Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment. Int J Bipolar Disord. 2017;5(1):9. https://doi.org/10.1186/s40345-017-0075-7 - PMid:28168632 PMCid:PMC5332323
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Filipe Freitas, Mateus Arruda Aleixo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
